Advertisement

Topics

Thomas, McNerney & Partners, LLC Company Profile

19:14 EDT 21st September 2017 | BioPortfolio

Thomas, McNerney & Partners is a health care venture capital firm with approximately $600 million under management focused on investing in life science and medical technology companies at all stages of development. In addition to helping entrepreneurs launch companies with seed and early stage funding, the firm provides growth capital to emerging companies to advance clinical development or for product commercialization. Thomas, McNerney & Partners also is involved in spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies and participating in structured financings for public companies as well as recapitalizations. The firm is targeting investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors and in other areas utilizing medical technology innovation. The firm has offices in Minneapolis, Stamford and San Francisco. For further information, please visit www.tm-partners.com.


News Articles [460 Associated News Articles listed on BioPortfolio]

Dr. Moneé Thomas Dermatologist Joins U.S. Dermatology Partners Bellaire Office August 14th

Dr. Moneé Thomas joins U.S. Dermatology Partners of Houston – Bellaire to serve patients Bellaire, River Oaks, Memorial, Tanglewood and West University neighborhoods. Houston, Texas (PRWEB) Jul...

My Moment with Jay Thomas

A departure from the usual FDA fare. The blog is meant to cover FDA issues, but also various aspects of communications. This is a story about media training, sort of. Jay Thomas died yesterday. He was...

Police finally track down Tennessee teacher and teen Elizabeth Thomas: Part 5

After living in the remote Black Bear Ranch commune, Cummins and Elizabeth Thomas were found in California.

Peter John Poels

bmj;357/may08_21/j2121/FAF1faPeter John Poels attended Beaumont School before doing his medical training at St Thomas’ Hospital. While at St Thomas’ he met Celia, and they married shortly after hi...

CDC directors old and new: What sets Brenda Fitzgerald and Thomas Frieden apart?

Brenda Fitzgerald has been appointed director of the Centers for Disease Control and Prevention. What differentiates her from Thomas Frieden, who previously held the role?

Merrimack appoints Thomas Needham chief business officer

Merrimack Pharmaceuticals announced further expansion of its executive management team with the appointment of Thomas E. Needham, Jr., M.B.A., to the position of chief business officer. In this role...

ThromboGenics appoints Thomas Clay as chairman

ThromboGenics NV, a biotechnology company developing novel treatments for diabetic eye disease, announces that the Board has appointed long─time non─executive director Thomas Clay as its next chai...

Cole-Parmer Collaborates with Guy’s and St Thomas’ NHS Foundation Trust to Advance Medical Research

Cole-Parmer Ltd have annouced that Stuart equipment is being used by Guy’s and St Thomas’ NHS Foundation Trust, located in London, to improve epidural anaesthesia. The Department of Obste...

Drugs and Medications [23 Associated Drugs and Medications listed on BioPortfolio]

Sweatblock [DC Alpine Partners, LLC DBA: Sweatblock]

SWEATBLOCK Clinical Strength Antiperspirant

Day cream mattifying hydrator [MOSAIC MARKETING PARTNERS LLC]

DAY CREAM MATTIFYING HYDRATOR

Ribavirin [Sandoz Inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. Ribavirin Tablets, oralInitial U.S. ...

Ribavirin [Cadila Healthcare Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribavirin [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

PubMed Articles [317 Associated PubMed Articles listed on BioPortfolio]

The Legacy of Thomas Hodgkin Is Still Relevant 150 Years After His Death. Nothing of Humanity Was Foreign to Him.

Current leading figures in medical science usually focus on very specific topics and use cutting-edge technologies to broaden our knowledge in the field. The working environment of the nineteenth cent...

Samuel Thomas Soemmerring (1755-1830): The Naming of Cranial Nerves.

Samuel Thomas Soemmerring was a Prussian polymathic doctor with remarkable achievements in anatomy, draftsmanship and inventions. His naming of 12 pairs of cranial nerves in his graduation thesis is o...

A qualitative study of secondary distribution of HIV self-test kits by female sex workers in Kenya.

Promoting awareness of serostatus and frequent HIV testing is especially important among high risk populations such as female sex workers (FSW) and their sexual partners. HIV self-testing is an approa...

Male engagement in women's microbicide use in Kenya: Navigating gender norms.

The success of women's microbicide use for HIV/AIDS prevention may hinge on health programs' ability to engage men to support it. In this qualitative study in Kenya, most women did not or would not te...

The German Focus on the Outcomes of Communication Under Six (FOCUS-G): Reliability and Validity of a Novel Assessment of Communicative Participation.

Our purpose was to explore the validity and reliability of the German Focus on the Outcomes of Communication Under Six (FOCUS-G; Thomas-Stonell, Oddson, Robertson, & Rosenbaum, 2010, 2012), which is a...

Clinical Trials [258 Associated Clinical Trials listed on BioPortfolio]

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Treatment for Men Who Are Abusive to Their Partners

This study will develop an individual behavior therapy for men who are violent toward their partners and will compare the therapy to standard group treatment.

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

This pilot clinical trial studies how well acceptance and commitment therapy works in improving well-being in patients with stage III-IV cancer and their partners. Learning how to accept n...

Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners

RATIONALE: Participating in a therapy program may enhance communication and intimacy between men with prostate cancer and their partners. PURPOSE: This randomized clinical trial is studyi...

A Case Control Study of Women With Multiple Sexual Partners

Both population based surveys and more focused research studies indicate that increased numbers of sexual partners and partner concurrency contribute to increased risk for acquisition of s...

Companies [973 Associated Companies listed on BioPortfolio]

Thomas, McNerney & Partners, LLC

Thomas, McNerney & Partners is a health care venture capital firm with approximately $600 million under management focused on investing in life science and medical technology companies at all stages o...

Atritech, Inc.

Atritech is a privately held company based in Plymouth, Minnesota. Major investors in Atritech include Split Rock Partners, Thomas, McNerney and Partners, Prism Venture Partners, Tullis Health Invest...

Ocera Therapeutics, Inc.

Ocera Therapeutics, based in San Diego, California, USA, is a privately held biopharmaceutical company focused on the development and commercialization of proprietary compounds to treat acute and chro...

Torax Medical, Inc.

Torax Medical, Inc. is a privately held medical device company headquartered in St. Paul, Minnesota that develops and markets products designed to treat sphincter disorders utiliz...

Thomas H. Lee Partners, L.P.

Thomas H. Lee Partners, L.P. ("THL") is one of the world's oldest and most experienced private equity firms. The firm invests in growth-oriented businesses, headquartered principa...

More Information about "Thomas, McNerney & Partners, LLC" on BioPortfolio

We have published hundreds of Thomas, McNerney & Partners, LLC news stories on BioPortfolio along with dozens of Thomas, McNerney & Partners, LLC Clinical Trials and PubMed Articles about Thomas, McNerney & Partners, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Thomas, McNerney & Partners, LLC Companies in our database. You can also find out about relevant Thomas, McNerney & Partners, LLC Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record